Nebenwirkungen · Humalog
Humalog 100 units/ml solution for injection in vial Humalog 100 units/ml solution for injection in cartridge Humalog 100 units/ml KwikPen solution for injection in a pre-filled pen Humalog 100 units/ml Junior KwikPen solution for injection in a pre-filled pen · Abschnitt 4.8 · PDF-Seite 7
HOS-085486 · Präparat HOS-083129
The following related adverse reactions from clinical trials are listed below as MedDRA preferred term by system organ class and in order of decreasing incidence (very common: ≥1/10; common: ≥1/100 to <1/10; uncommon: ≥1/1,000 to <1/100; rare: ≥1/10,000 to <1/1,000; very rare: <1/10,000) ; not known (cannot be estimated form the available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-13T17:33:00Z · SHA-256 346311c779d97c64bfc351999eb6d3faf359f3deec2a8964d33b453a851cb74f · Passage 2969d926316c9a3eb88a6ca076f0ebb7ca684b212fc0f6384115d459d60882e5 · Zeichen 438–785 im Abschnitt